News

Investigational Insulin Analogue Effective, Safe in Early Trials

Publish date: August 1, 2010
PDF Download

 

From the annual scientific sessions of the American Diabetes Association

At the trial's end, mean daily insulin doses were lower for the analogue than for glargine.

Source DR. HEISE

Pages

Recommended Reading

Diabetes in Men: Peer Support Boosts Control : Intervention saved staff time and resources, in addition to lowering HbA1c levels in patients.
Type 2 Diabetes ICYMI
Vascular Disease Doubles Risk of MRSA Treatment Failure
Type 2 Diabetes ICYMI
Snoring Linked to Gestational Diabetes Risk : Habitual snorers had significantly higher blood glucose levels after a 1-hour tolerance test.
Type 2 Diabetes ICYMI
White Rice Raised Diabetes Risk 17%, Over Brown Rice
Type 2 Diabetes ICYMI
Innovations Steadily Advance Artificial Pancreas
Type 2 Diabetes ICYMI
Alert Patients to Heat's Impact on Diabetes
Type 2 Diabetes ICYMI
ADA, ACS Spotlight Diabetes-Cancer Links
Type 2 Diabetes ICYMI
Another Defeat for Conventional Wisdom
Type 2 Diabetes ICYMI
Antidepressants in Patients with Diabetes
Type 2 Diabetes ICYMI
Bariatric surgery for type 2 diabetes: Weighing the impact for obese patients
Type 2 Diabetes ICYMI